Table 2 Results At 2 months by patient group (*1 patient died prior to the first evaluation and has been classified as progressive disease).
Partial Response (%) | Stable Disease (%) | Progressive Disease (%) | |
|---|---|---|---|
Overall (n = 30) | 10 (33%) | 8 (27%) | 12 (40%)* |
Failed 5FU alone (n = 8) | 6 | 1 | 1* |
Failed 5FU and CPT-11 and Oxal (n = 14) containing regimens | 3 | 2 | 8 |
Failed 5FU and either CPT-11 or Oxaliplatin (n = 8) containing regimens | 2 | 2 | 4 |
Extra-Hepatic disease (n = 7) | 0 | 2 | 5 |
ECOG 2 (n = 3) | 0 | 1 | 2 |